Updated Jul 16, 2026
Galli Stephen J has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Stephen J. Galli is identified in SEC filings as an insider associated with Atossa Therapeutics, Inc. as of the filing dated 2026-05-14. The publicly available context provided here does not include a detailed personal biography, title, or tenure beyond his connection to Atossa Therapeutics. Atossa Therapeutics is a publicly traded biotechnology company. Based on the SEC context alone, this entry reflects a corporate insider relationship rather than a broader public biographical profile.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | ATOS | ATOSSA THERAPEUTICS, INC. | A — Grant or award | 10.0K | $0.00 |
Stephen J. Galli is identified in SEC filings as an insider associated with Atossa Therapeutics, Inc. as of the filing dated 2026-05-14. The publicly available context provided here does not include a detailed personal biography, title, or tenure beyond his connection to Atossa Therapeutics. Atossa Therapeutics is a publicly traded biotechnology company. Based on the SEC contex…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Galli Stephen J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.